Tag: HIV
-
Start-Up Lands $10M for Gene-Editing HIV Treatments
A new enterprise developing treatments using gene editing to eliminate HIV infections received $10 million in its seed funding round.
-
Gene Editing Could Lead to an HIV Cure
Researchers at Temple University and the University of Pittsburgh published a study, which involved gene editing to remove HIV DNA from rat and mouse models.
-
Messenger RNA Engineered to Produce Antibodies
Academic and industry researchers demonstrated production of therapeutic antibodies inside cells of lab mice, offering a simpler and lower-cost alternative to monoclonal antibodies.
-
Biotech, Univ of Miami Spin-Off Vaccine Company
Biotechnology company Heat Biologics Inc. is licensing research from University of Miami in Florida to develop vaccines against infectious diseases, starting with the Zika virus, in a new subsidiary.
-
Refillable HIV Prevention Implant in Development
A device implanted under the skin providing 60 days of antiretroviral drugs to prevent HIV infection is in development at Houston Methodist Research Institute.
-
Start-Up Licenses Genetics Technology for HIV Diagnostics
19 May 2016. A spin-off company from Harvard University is licensing genetics research to develop more powerful tools to detect drug-resistant strains of HIV. Financial details of the agreement between the 2 year-old Aldatu Biosciences Inc. and Harvard were not disclosed. Aldatu Biosciences is the creation of pathologist Iain MacLeod and geneticist David Raiser that…
-
Gates Funding RNA Treatment for HIV Infection
12 January 2016. The Bill and Melinda Gates Foundation is backing a biotechnology company’s early development of antibodies to treat human immunodeficiency virus or HIV based on RNA, nucleic acids expressed by a person’s genetic code. The foundation is supporting the work of Moderna Therapeutics, in Cambridge, Massachusetts, with an initial $20 million grant, and…
-
USC, Biotech Edit Genes in Stem Cells for HIV Therapy
10 November 2015. A lab at University of Southern California and biotechnology company developed a technique for editing genomes in blood-forming stem cells as a potential treatment for HIV infection. The team from the lab of USC medical school professor Paula Cannon and Sangamo BioSciences in Richmond, California published its findings yesterday in the journal…
-
Research Group, CureVac Partner on AIDS Vaccine
10 September 2015. An organization encouraging development of AIDS vaccines and the pharmaceutical company CureVac are collaborating on creating a potent AIDS vaccine technology. Financial and intellectual property aspects of the partnership between the not-for-profit International AIDS Vaccine Initiative, or IAVI, and CureVac in Tubingen, Germany were not disclosed. IAVI sponsors research and development of…
-
Preventive Drugs Found to Stop New HIV Infections
2 September 2015. A large-scale study of preexposure prophylaxis or PrEP, the use of antiviral drugs to prevent HIV infection, found the practice prevented new HIV infections among Kaiser Permanente clients in San Francisco over a 32-month period. Results of the study led by Kaiser Permanente epidemiologist Jonathan Volk, appear in yesterday’s issue of the…